test

Oleg Nodelman

@Ecor1 Capital, Llc

Latest period2024 - Q3ReportedManaged Assets$2.922BTotal holdings63
Assets growth rate-10.62%Assets growth rate (2-Q avg)-13.97%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Ecor1 Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 63 positions.

Assets under management

The assets under management (AUM) of Ecor1 Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.922B in assets, with a quarterly growth rate of -10.62% and a 2-quarter average growth rate of -13.97%. The portfolio is managed by Oleg Nodelman, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
JANXJanux Therapeutics Inc
Recent Activity
2.29%
$66.774M
1.47M shares@ $45.44 avg price
CRSPCrispr Therapeutics Ag
Recent Activity
2.24%
$65.268M
1.389M shares@ $46.98 avg price
IMNMImmunome Inc
Recent Activity
1.95%
$56.717M
3.879M shares@ $14.62 avg price
NGNENeurogene Inc
Recent Activity
1.83%
$53.346M
1.271M shares@ $41.96 avg price
CNTACentessa Pharmaceuticals Plc
Recent Activity
Decreased -43.58%
1.77%
$51.549M
3.224M shares@ $15.99 avg price
VRDNViridian Therapeutics Inc
Recent Activity
New Position
1.53%
$44.564M
1.959M shares@ $22.75 avg price
NUVBNuvation Bio Inc
Recent Activity
1.51%
$43.99M
19.21M shares@ $2.29 avg price
THRDThird Harmonic Bio Inc
Recent Activity
1.48%
$43.122M
3.182M shares@ $13.55 avg price
PCVXVaxcyte Inc
Recent Activity
Increased 17.49%
1.38%
$40.276M
352,464 shares@ $114.27 avg price
MRSNMersana Therapeutics Inc
Recent Activity
1.26%
$36.599M
19.365M shares@ $1.89 avg price